Polynucleotide injections have revolutionized regenerative aesthetics, offering practitioners a powerful tool for tissue repair and skin rejuvenation. As demand for biostimulatory treatments grows, understanding the science, applications, and clinical protocols for polynucleotide therapy becomes essential for delivering exceptional patient outcomes. This comprehensive guide provides practitioners with everything needed to successfully integrate polynucleotide injections into their practice.

Understanding Polynucleotides in Aesthetic Medicine

Polynucleotides (PN) are biopolymers composed of nucleotide chains—the fundamental building blocks of DNA and RNA. In aesthetic medicine, polynucleotides are typically extracted from salmon DNA through specialized purification processes, resulting in biocompatible molecules that trigger powerful regenerative responses in human tissue.

Unlike traditional dermal fillers that mechanically fill tissue, polynucleotides work at the cellular level to repair, regenerate, and restore skin health from within. This makes them ideal for patients seeking natural rejuvenation without dramatic volumizing effects.

The Science Behind Polynucleotide Therapy

Polynucleotides exert their therapeutic effects through multiple biological mechanisms:

Cellular Regeneration: PN molecules bind to specific cell surface receptors, activating signaling pathways that promote DNA repair and cell proliferation. This helps damaged tissue regenerate more effectively.

Collagen and Elastin Synthesis: Fibroblasts stimulated by polynucleotides increase production of collagen type I and III, as well as elastin fibers. This gradually restores structural integrity to aging or damaged skin.

Anti-Inflammatory Action: Polynucleotides possess inherent anti-inflammatory properties, reducing chronic inflammation that accelerates skin aging and impairs healing.

Antioxidant Protection: PN molecules scavenge free radicals, protecting cells from oxidative stress caused by UV radiation, pollution, and natural metabolic processes.

Improved Microcirculation: Enhanced angiogenesis increases blood flow to treated areas, delivering more oxygen and nutrients while removing metabolic waste products more efficiently.

Tissue Hydration: Polynucleotides improve the skin’s water-binding capacity, creating lasting hydration improvements beyond what standard skin boosters achieve.

Clinical Indications for Polynucleotide Injections

Polynucleotide therapy addresses a wide range of aesthetic and medical concerns:

Primary Aesthetic Applications

Skin Quality Improvement: Polynucleotides excel at improving overall skin texture, tone, and radiance. Patients notice smoother, more refined skin with reduced pore visibility and improved clarity.

Fine Lines and Crepey Skin: The treatment effectively addresses thin, fragile skin prone to fine wrinkling, particularly in areas like the neck, décolletage, and around the eyes where traditional fillers may not be appropriate.

Volume Loss and Tissue Laxity: While not volumizers themselves, polynucleotides improve tissue density and elasticity, creating subtle lifting and tightening effects through enhanced collagen production.

Scar Treatment: Polynucleotide injections show remarkable efficacy in treating atrophic scars, including acne scars, surgical scars, and traumatic scars. The regenerative properties help remodel scar tissue and restore normal skin architecture.

Under-Eye Concerns: Polynucleotides address dark circles, fine lines, and crepey texture in the delicate periorbital area where heavy fillers may create complications.

Stretch Marks: The regenerative effects can improve the appearance of striae by stimulating collagen production and improving skin quality in affected areas.

Advanced Clinical Applications

Post-Procedure Recovery: Polynucleotides accelerate healing after laser treatments, chemical peels, or ablative procedures by supporting tissue repair mechanisms.

Preventive Anti-Aging: Younger patients use polynucleotide therapy to maintain skin quality and delay visible aging before structural changes become pronounced.

Combination Protocols: Polynucleotides enhance outcomes when combined with dermal fillers, such as Restylane Kysse for lip and perioral rejuvenation,creating healthier tissue environments that may extend filler longevity and improve integration.

Polynucleotide Injection Techniques

Success with polynucleotide therapy requires mastering appropriate injection techniques for different treatment areas.

Injection Methods

Microinjection Technique (Nappage): Multiple superficial injections placed 0.5-1cm apart throughout the treatment area. This distributes the product evenly and maximizes tissue coverage. Ideal for general skin quality improvement.

Serial Puncture: Individual injections placed in a grid pattern, slightly deeper than nappage. Provides more focused treatment to specific areas with greater concern.

Linear Threading: Product deposited in linear threads using a cannula or needle. Effective for treating larger areas or addressing linear scars.

Cross-Hatching: Intersecting linear threads create comprehensive coverage. Particularly useful for scar remodeling.

Blanching Technique: Small boluses injected until slight blanching appears, indicating adequate product placement. Used for targeted scar treatment.

Treatment Area Protocols

Face (Full): 2-4ml total volume distributed across cheeks, forehead, perioral area, and jawline. Use superficial to mid-dermal injection depth.

Under Eyes: 0.5-1ml per side using very superficial microinjections with 32G or finer needles. Extreme caution required to avoid vascular complications.

Neck and Décolletage: 2-3ml using microinjection technique to address crepey skin and fine lines. These areas respond particularly well to polynucleotide therapy.

Hands: 1-2ml per hand using linear threading or microinjection to improve skin quality and reduce visible veins.

Acne Scars: 0.1-0.2ml per scar using precise injections directly into scar tissue. Multiple sessions required for optimal remodeling.

Stretch Marks: Linear threading along the length of striae with 0.5-1ml per 10cm of stretch mark.

Injection Depth Considerations

Superficial Dermis: For overall skin quality, texture, and fine line reduction. Provides the most dramatic improvements in skin appearance.

Mid-Dermis: For deeper structural concerns, scar remodeling, and elasticity improvement. Stimulates more robust collagen production.

Avoid Subcutaneous Placement: Polynucleotides work best in the dermis where they can interact with fibroblasts. Subcutaneous injection provides minimal benefit.

Treatment Protocols and Schedules

Standard Treatment Series

Initial Course: 3-4 treatments spaced 2-4 weeks apart establish optimal results. This loading phase saturates tissue with polynucleotides and triggers sustained collagen production.

Maintenance Phase: After completing the initial series, maintenance treatments every 6-12 months sustain improvements. Some patients prefer quarterly treatments for optimal results.

Intensive Protocols

Scar Treatment: Monthly treatments for 6-8 months provide comprehensive scar remodeling. Severe scars may require extended protocols.

Significant Sun Damage: Weekly treatments for 4 weeks, followed by monthly treatments for 3 months, address severe photodamage.

Post-Procedure Recovery: Single treatment immediately after laser or chemical peel procedures, with optional follow-up at 2 weeks.

Combination Treatment Timing

With Dermal Fillers: Administer polynucleotides 2 weeks before filler treatments to optimize tissue quality, or 2-4 weeks after to support integration.

With Botulinum Toxin: Can be performed in the same session with strategic area separation. Address different anatomical zones to avoid interference.

With Laser Treatments: Administer 1-2 weeks after ablative procedures to accelerate healing. Can be performed 2-4 weeks before non-ablative treatments.

Polynucleotides Under Eyes: Special Considerations

The under-eye area requires particular attention due to its delicate nature and vascular complexity.

Assessment for Under-Eye Treatment

Ideal candidates present with fine lines and crepey texture, mild volume loss without significant hollowing, dark circles from poor skin quality rather than vascular causes, and realistic expectations about gradual improvement.

Not suitable for: Severe tear trough deformity requiring volumizing fillers, prominent vascular dark circles, active infections or inflammation, and patients with unrealistic expectations about immediate results.

Under-Eye Injection Technique

Preparation: Apply topical anesthetic 30 minutes before treatment, mark the tear trough and lower eyelid, and use cold compresses to constrict vessels.

Injection Method: Use 30-32G needle or blunt-tip 27G cannula, inject very superficially in the dermis (avoid too deep), place multiple small aliquots (0.01-0.02ml per injection point), and avoid the orbital rim and direct tear trough area.

Volume: 0.5-1ml total per under-eye area, distributed across multiple injection points.

Safety: Always aspirate before injection, avoid known vascular pathways, have hyaluronidase available despite low risk, and watch for signs of vascular compromise immediately post-treatment.

Managing Patient Expectations

Realistic Timeline of Results

Immediate (Days 1-7): Mild swelling and potential bruising, small bumps at injection sites (normal), slight improvement in hydration.

Early Phase (Weeks 2-4): Reduced inflammation, beginning texture improvements, subtle enhancement in skin quality.

Progressive Results (Months 1-3): Gradual collagen remodeling, continued improvement in texture and tone, increased skin firmness and elasticity.

Optimal Outcomes (Months 3-6): Peak results visible, sustained improvements in skin quality, maintained collagen production.

Long-Term (6-12 Months): Results gradually plateau but remain stable, maintenance treatments recommended to sustain benefits.

Setting Appropriate Expectations

Polynucleotide injections provide natural, gradual improvements rather than immediate dramatic changes. Patients should understand that multiple treatments build cumulative effects, results vary based on age, skin condition, and lifestyle factors, and optimal outcomes require patience—typically 3-6 months for full results.

Side Effects and Complications

Common Post-Treatment Effects

Expected Reactions: Injection site bumps (resolve within 24-48 hours), mild erythema (resolves within hours to days), slight swelling (peaks at 24-48 hours), temporary tenderness at injection sites.

Management: Apply cold compresses immediately after treatment, sleep elevated the first night post-treatment, avoid strenuous exercise for 24 hours, and use gentle skincare for 48 hours.

Rare Complications

Bruising: More common in vascular areas like under eyes. Advise patients to discontinue blood-thinning supplements before treatment and apply arnica topically post-treatment.

Prolonged Swelling: If swelling persists beyond 5 days, evaluate for infection or allergic reaction. Consider oral antihistamines for mild cases.

Infection: Extremely rare with proper sterile technique. Treat with appropriate antibiotics if suspected.

Allergic Reactions: Very uncommon but possible. Screen patients for fish/seafood allergies during consultation.

Vascular Complications: Exceptionally rare with polynucleotides due to lower viscosity than fillers. However, maintain vigilance and proper technique, especially in high-risk areas.

Patient Selection and Contraindications

Ideal Candidates

Best suited for patients aged 30-70 seeking natural rejuvenation, those with good skin quality but early signs of aging, patients interested in preventive anti-aging approaches, individuals with realistic expectations about gradual improvement, and those committed to treatment series for optimal results.

Contraindications

Absolute: Pregnancy and breastfeeding, active infection in treatment area, known allergy to fish or seafood products, and autoimmune diseases affecting skin.

Relative: Active acne or rosacea (may treat once controlled), unrealistic expectations about immediate results, inability to comply with post-treatment care, and recent ablative procedures (wait 2-4 weeks).

Building Your Polynucleotide Practice

Successfully integrating polynucleotide injections requires strategic practice development:

Education and Marketing: Educate patients about regenerative aesthetics and biostimulation, use before-and-after photography to document gradual improvements, and share information with appropriate compliance.

Product Selection: Source high-quality, certified polynucleotide products from reputable suppliers who provide proper documentation and support.

Treatment Packages: Offer series packages to improve patient compliance and ensure optimal outcomes. Package pricing encourages completion of initial treatment courses.

Staff Training: Ensure all clinical staff understand polynucleotide mechanisms, benefits, and realistic timelines. Consistent messaging improves patient satisfaction.

Documentation: Maintain detailed records including standardized photography, treatment parameters, and patient response. This documentation supports outcome assessment and treatment refinement.

Polynucleotide Therapy in Modern Aesthetic Practice

Polynucleotide injections represent the future of regenerative aesthetic medicine—treatments that work with the body’s natural healing mechanisms to create lasting improvements in skin health and appearance.

For practitioners, mastering polynucleotide therapy requires understanding the underlying science, developing precise injection techniques, and effectively communicating realistic expectations to patients. When integrated strategically with other treatments, polynucleotides provide comprehensive solutions for modern aesthetic concerns.

The growing demand for natural, regenerative treatments positions polynucleotide therapy as an essential component of contemporary aesthetic practice. By offering these innovative treatments, practitioners can differentiate their services, attract patients seeking cutting-edge solutions, and deliver results that align with the trend toward subtle, natural rejuvenation.

Success with polynucleotide injections depends on patient selection, proper technique, realistic expectation-setting, and commitment to ongoing education. As the field continues to evolve, staying current with emerging research and clinical protocols ensures practitioners can provide the highest standard of care to their patients.

Ready to expand your injectable expertise? Learn about building a successful injectable practice and finding new aesthetic clients.